Spinal muscular atrophy: Clinical classification and disease heterogeneity

被引:161
|
作者
Russman, Barry S.
机构
[1] Shriners Hosp Children, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
关键词
spinal muscular atrophy; anterior horn cell; SMN1; gene;
D O I
10.1177/0883073807305673
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The clinical classification of spinal muscular atrophy, caused by deletion of the survival motor neuron I gene (SMNI), is based on age at onset and maximum function achieved. Evidence suggests that maximum function achieved is more closely related to life expectancy than age at onset. Therefore, it is important to wait for a period before assigning a patient to I of 5 classes of the disorder. Several diseases result from degeneration of the anterior horn cell but are not caused by SMN1. The classification for these conditions is evolving. This article offers an attempt at organizing one's thinking about this disease group.
引用
收藏
页码:946 / 951
页数:6
相关论文
共 50 条
  • [21] Spinal Muscular Atrophy
    Vitte, Jeremie
    Attali, Ruben
    Warwar, Nasim
    Gurt, Irena
    Melki, Judith
    INHERITED NEUROMUSCULAR DISEASES: TRANSLATION FROM PATHMECHANISMS TO THERAPIES, 2009, 652 : 237 - 246
  • [22] Spinal muscular atrophy
    Iannaccone S.T.
    Smith S.A.
    Simard L.R.
    Current Neurology and Neuroscience Reports, 2004, 4 (1) : 74 - 80
  • [23] Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance
    Keinath, Melissa C.
    Prior, Devin E.
    Prior, Thomas W.
    APPLICATION OF CLINICAL GENETICS, 2021, 14 : 11 - 25
  • [24] Spinal muscular atrophy
    Martin, Pascal
    Horber, Veronka
    Park, Joohyun
    Kronlage, Cornelius
    Grimm, Alexander
    NERVENARZT, 2022, 93 (02): : 191 - 200
  • [25] The systemic complexity of a monogenic disease: the molecular network of spinal muscular atrophy
    Tapken, Ines
    Schweitzer, Theresa
    Paganin, Martina
    Schuening, Tobias
    Detering, Nora T.
    Sharma, Gaurav
    Niesert, Moritz
    Saffari, Afshin
    Kuhn, Daniela
    Glynn, Amy
    Cieri, Federica
    Santonicola, Pamela
    Cannet, Claire
    Gerstner, Florian
    Faller, Kiterie M. E.
    Huang, Yu-Ting
    Kothary, Rashmi
    Gillingwater, Thomas H.
    Di Schiavi, Elia
    Simon, Christian M.
    Hensel, Niko
    Ziegler, Andreas
    Viero, Gabriella
    Pich, Andreas
    Claus, Peter
    BRAIN, 2024, 148 (02) : 580 - 596
  • [26] Spinal muscular atrophy: Classification, aetiology, and treatment of spinal deformity in children and adolescents
    Tsirikos, Athanasios I.
    Baker, Alexander D. L.
    CURRENT ORTHOPAEDICS, 2006, 20 (06): : 430 - 445
  • [27] Advances in spinal muscular atrophy therapeutics
    Parente, Valeria
    Corti, Stefania
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [28] Spinal muscular atrophy
    Oskoui, Maryam
    Kaufmann, Petra
    NEUROTHERAPEUTICS, 2008, 5 (04) : 499 - 506
  • [29] TREATMENT STRATEGIES FOR SPINAL MUSCULAR ATROPHY
    Fuller, Heidi R.
    Barisic, Marija
    Seso-Simic, Durdica
    Speljko, Tea
    Morris, Glenn E.
    Simic, Goran
    TRANSLATIONAL NEUROSCIENCE, 2010, 1 (04) : 308 - 321
  • [30] Development of an academic disease registry for spinal muscular atrophy
    Mercuri, Eugenio
    Finkel, Richard
    Scoto, MariaCristina
    Hall, Susan
    Eaton, Susan
    Rashid, Aisha
    Balashkina, Julia
    Coratti, Giorgia
    Pera, Maria Carmela
    Samsuddin, Salma
    Civitello, Matthew
    Muntoni, Francesco
    De Vivo, Darryl C.
    Darras, Basil T.
    Day, John
    Montes, Jacqueline
    Glanzmann, Allan
    Pasternack, Amy
    Salazar, Rachel
    Young, Sally Dunaway
    Duong, Tina
    Pane, Marika
    Berti, Beatrice
    Palermo, Concetta
    Leone, Daniela
    Frongia, Annalia
    Antonaci, Laura
    De Sanctis, Roberto
    Messina, Sonia
    Bertini, Enrico
    Vita, Giuseppe
    Bruno, Claudio
    Sframeli, Maria
    Sansone, Valeria A.
    Albamonte, Emilio
    D'Amico, Adele
    NEUROMUSCULAR DISORDERS, 2019, 29 (10) : 794 - 799